CHEK2 and breast carcinoma: One possible explanation is that the impact of PGS313 on OS may be confounded by other genetic risk factors, many of which have yet to be identified; several recent papers have found that PGS313 stratifies breast cancer risk in CHEK2, PALB2, and ATM carriers but not BRCA1/2 carriers.15